Get the Stockscreener App
3.325
0.08%
0.015
Immunitybio Inc Stock (IBRX) Forecast
The Immunitybio Inc (IBRX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $15.88, representing a +377.62% increase from the current price of $3.325. The highest analyst price target is $15.87, and the lowest is $15.90.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month IBRX Price Target
Average 13.88
(+317.42% Upside)
Is Immunitybio Inc (IBRX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 54.51 | Neutral |
| STOCH(9,6) | 45.41 | Neutral |
| STOCHRSI(14) | 44.25 | Neutral |
| MACD(12,26) | 0.0437 | Buy |
| ADX(14) | 20.18 | Neutral |
| William %R | -46.67 | Neutral |
| CCI(14) | 22.55 | Neutral |
Buy: 1
Sell: 0
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
3.248
Buy
|
3.2231
Buy
|
| MA20 |
3.04
Buy
|
3.148
Buy
|
| MA50 |
3.3334
Sell
|
3.3484
Sell
|
| MA100 |
3.8021
Sell
|
3.7516
Sell
|
| MA200 |
4.8238
Sell
|
4.0389
Sell
|
Buy: 4
Sell: 6
Neutral: 0
Summary: Sell
According to our latest analysis, IBRX could be considered a Neutral, with 17 technical analysis indicators signaling 5 Buy signals, 6 signaling Sell signals and 6 Neutral signals. This suggests that investors should exercise caution when entering new positions on IBRX, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 54.51 indicates that IBRX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 45.41 indicates that IBRX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 44.25 indicates that IBRX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 20.18 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 22.55 indicates that IBRX is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term IBRX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Immunitybio Inc financial reports and earnings history, Immunitybio Inc (IBRX) stock could reach $25.62 by 2030, $93.01 by 2040 and $178.73 by 2050. See the projected annual prices until 2050 of the Immunitybio Inc stock below:
- Immunitybio Inc (IBRX) is expected to reach an average price of $13.72 in 2035, with a high prediction of $15.23 and a low estimate of $12.22. This indicates an $312.74% rise from the last recorded price of $3.325.
- Immunitybio Inc (IBRX) stock is projected to chart a bullish course in 2040, with an average price target of $91.83, representing an $2,662% surge from its current level. The forecast ranges from a conservative $92.26 to a sky-high $93.01.
- Our analysts predict Immunitybio Inc (IBRX) to jump 1,836% by 2045, soaring from $64.39 to an average price of $64.37, potentially reaching $65.83. While $64.39 is the low estimate, the potential upside is significant.
- Immunitybio Inc (IBRX) stock is expected to climb by 2050, reaching an average of $178.16, a $5,258% jump from its current level. However, a wide range of estimates exists, with high and low targets of $178.73 and $178.22, respectively, highlighting the market's uncertainty.
Immunitybio Inc Stock (IBRX) Year by Year Forecast
Immunitybio Inc Stock (IBRX) Price Forecast for 2025
Immunitybio Inc Stock (IBRX) is expected to reach an average price of $14.75 in 2025, with a high prediction of $15.87 and a low estimate of $13.63. This indicates an +343.61% rise from the last recorded price of $3.325.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| March, 2025 | $15.87 | $15.90 | $15.87 | +377.19% |
| April, 2025 | $15.58 | $15.83 | $15.66 | +368.52% |
| May, 2025 | $14.08 | $15.02 | $15.18 | +323.45% |
| June, 2025 | $14.60 | $14.29 | $14.19 | +339.14% |
| July, 2025 | $14.92 | $14.68 | $14.64 | +348.81% |
| August, 2025 | $16.04 | $15.70 | $15.82 | +382.54% |
| September, 2025 | $15.45 | $15.60 | $15.31 | +364.54% |
| October, 2025 | $14.56 | $14.73 | $15.53 | +337.83% |
| November, 2025 | $14.22 | $14.19 | $13.70 | +327.64% |
| December, 2025 | $13.56 | $13.63 | $13.46 | +307.85% |
Immunitybio Inc Stock (IBRX) Price Forecast for 2026
The predicted value for Immunitybio Inc (IBRX) in 2026 is set at an average of $11.05. Estimates vary from a peak of $12.95 to a trough of $9.1482, indicating an +232.25% surge from the present price of $3.325.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $12.29 | $12.44 | $12.95 | +269.70% |
| February, 2026 | $11.37 | $11.89 | $11.48 | +242.07% |
| March, 2026 | $10.41 | $10.98 | $10.68 | +212.94% |
| April, 2026 | $9.5471 | $10.09 | $10.42 | +187.13% |
| May, 2026 | $10.93 | $10.06 | $10.01 | +228.68% |
| June, 2026 | $11.02 | $10.70 | $10.80 | +231.43% |
| July, 2026 | $11.83 | $10.85 | $11.55 | +255.84% |
| August, 2026 | $12.19 | $12.43 | $12.35 | +266.71% |
| September, 2026 | $10.49 | $11.05 | $11.73 | +215.34% |
| October, 2026 | $10.31 | $10.40 | $9.6964 | +209.97% |
| November, 2026 | $9.6679 | $9.7679 | $9.9868 | +190.76% |
| December, 2026 | $9.0497 | $9.1482 | $9.3882 | +172.17% |
Immunitybio Inc Stock (IBRX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Immunitybio Inc (IBRX) is $15.11, with a high forecast of $29.37 and a low forecast of $0.853. This indicates an +354.51% increase from the last price of $3.325.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $9.5911 | $9.4604 | $9.4211 | +188.45% |
| February, 2027 | $9.4526 | $9.4726 | $9.3626 | +184.29% |
| March, 2027 | $9.0144 | $9.0836 | $9.2829 | +171.11% |
| April, 2027 | $6.8558 | $7.4358 | $8.8297 | +106.19% |
| May, 2027 | $5.4372 | $5.8422 | $5.9565 | +63.53% |
| June, 2027 | $4.569 | $4.949 | $5.538 | +37.41% |
| July, 2027 | $4.9705 | $4.4398 | $4.7205 | +49.49% |
| August, 2027 | $3.5519 | $4.3719 | $4.6112 | +6.82% |
| September, 2027 | $2.0937 | $3.0034 | $3.1023 | -37.03% |
| October, 2027 | $1.4352 | $2.2552 | $1.9341 | -56.84% |
| November, 2027 | $1.2834 | $1.1934 | $3.8234 | -61.40% |
| December, 2027 | $30.92 | $0.853 | $29.37 | +829.99% |
Immunitybio Inc Stock (IBRX) Price Forecast for 2028
In 2028, Immunitybio Inc (IBRX) is projected to reach an average price of $36.32, with a high projection of $38.14 and a low estimate of $34.51. This indicates an +992.48% rise from the last price of $3.325.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $34.70 | $34.89 | $34.28 | +943.46% |
| February, 2028 | $34.02 | $36.03 | $34.29 | +923.10% |
| March, 2028 | $36.19 | $34.51 | $36.03 | +988.47% |
| April, 2028 | $38.78 | $36.67 | $37.76 | +1,066% |
| May, 2028 | $37.18 | $38.32 | $37.66 | +1,018% |
| June, 2028 | $37.44 | $37.18 | $37.34 | +1,026% |
| July, 2028 | $37.92 | $37.56 | $36.83 | +1,041% |
| August, 2028 | $37.93 | $37.71 | $37.68 | +1,041% |
| September, 2028 | $38.93 | $38.80 | $38.11 | +1,071% |
| October, 2028 | $37.81 | $37.84 | $38.14 | +1,037% |
| November, 2028 | $36.98 | $37.56 | $37.17 | +1,012% |
| December, 2028 | $35.04 | $35.98 | $36.47 | +953.82% |
Immunitybio Inc Stock (IBRX) Price Forecast for 2029
The 2029 price forecast for Immunitybio Inc Stock (IBRX) is $30.50 on average, with a high prediction of $35.35 and a low estimate of $25.64. This represents an +817.28% increase from the previous price of $3.325.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $35.08 | $35.14 | $34.71 | +955.13% |
| February, 2029 | $34.90 | $34.87 | $34.62 | +949.51% |
| March, 2029 | $35.58 | $35.57 | $35.35 | +970.04% |
| April, 2029 | $34.54 | $34.81 | $34.74 | +938.85% |
| May, 2029 | $33.11 | $33.28 | $34.40 | +895.65% |
| June, 2029 | $32.33 | $32.37 | $32.01 | +872.28% |
| July, 2029 | $31.25 | $31.52 | $31.46 | +839.89% |
| August, 2029 | $29.41 | $29.56 | $30.99 | +784.66% |
| September, 2029 | $28.06 | $28.59 | $28.50 | +743.84% |
| October, 2029 | $27.00 | $27.03 | $27.15 | +712.07% |
| November, 2029 | $25.24 | $25.78 | $26.45 | +659.22% |
| December, 2029 | $26.19 | $25.64 | $25.27 | +687.58% |
Immunitybio Inc Stock (IBRX) Price Forecast for 2030
Immunitybio Inc Stock (IBRX) is expected to reach an average price of $20.85 in 2030, with a high forecast of $26.30 and a low forecast of $15.40. This signifies an +527.00% surge from the last price of $3.325.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $25.09 | $25.70 | $25.62 | +654.61% |
| February, 2030 | $26.10 | $25.45 | $25.82 | +685.07% |
| March, 2030 | $26.03 | $26.35 | $26.30 | +682.75% |
| April, 2030 | $24.11 | $24.88 | $25.43 | +625.09% |
| May, 2030 | $23.15 | $23.36 | $23.68 | +596.33% |
| June, 2030 | $22.08 | $22.18 | $22.72 | +563.93% |
| July, 2030 | $20.91 | $21.01 | $21.69 | +528.85% |
| August, 2030 | $21.01 | $21.10 | $20.96 | +531.95% |
| September, 2030 | $20.44 | $20.46 | $20.58 | +514.59% |
| October, 2030 | $19.45 | $19.56 | $20.16 | +484.92% |
| November, 2030 | $16.85 | $17.43 | $19.15 | +406.82% |
| December, 2030 | $14.99 | $15.40 | $15.73 | +350.96% |
0.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):